Pharmedic Pharmaceuticals

What Pharmedic Pharmaceuticals does

Pharmedic Pharmaceuticals is a privately held Brazilian pharmaceutical company headquartered in São Caetano Do Sul, founded in 2004 and operating with a workforce of 51-100 employees. Per its stated positioning, the company produces orphan drugs for rare diseases and concurrently offers aesthetic/beauty products such as wrinkle fillers, indicating a dual therapeutic-and-consumer portfolio strategy. The combination of a niche, low-volume orphan-drug franchise with a higher-volume aesthetics line is structurally unusual and suggests a deliberate risk-mix strategy typical of smaller Brazilian specialty pharma operators seeking to balance regulated pharmaceutical margins against consumer-driven volume.

The company's revenue model, pricing structure, and go-to-market mechanics are not disclosed in the available source material. Orphan drugs are typically distributed through hospital tenders, specialty pharmacy channels, or government procurement programs, while aesthetic products such as wrinkle fillers are generally sold through dermatology clinics, medical spas, and retail pharmacy channels. The blend of these two channels implies a multi-channel commercial operation, but the relative weighting between pharmaceutical and consumer lines — and the resulting revenue concentration — cannot be determined from current data.

The underlying technology stack, proprietary formulations, manufacturing footprint, regulatory certifications (e.g., ANVISA GMP status), and intellectual property position are likewise undocumented in the source set. The company's own web domain (pharmedic.com.br) is confirmed to exist but presents only a security-verification interstitial, providing no substantive corporate disclosure. As a result, several diligence-critical dimensions — including ownership structure, board composition, management team, R&D pipeline depth, and capital base — remain unverified, and any PE/VC/M&A thesis would require primary-source diligence to fill these gaps.

Name

Pharmedic Pharmaceuticals

Website

https://pharmedic.com.br

Company type

Private

Founded year

2004

Headcount range

1–10 employees

Short description

Pharmedic Pharmaceuticals is a privately held Brazilian pharmaceutical company that manufactures orphan drugs for rare diseases and aesthetic products such as wrinkle fillers, operating from São Caetano Do Sul with 51-100 employees.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

Keywords

• Orphan drugs
• Rare disease treatments
• Dermal fillers
• Specialty pharmaceuticals
• Aesthetic injectables

Headquarters

HQ city

São Caetano Do Sul

HQ country

Brazil

HQ region

Latin America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Core offering

Pharmedic Pharmaceuticals manufactures and supplies pharmaceutical products, including orphan drugs intended for the treatment of rare diseases. In parallel, the company offers a line of beauty products such as wrinkle fillers, serving aesthetic use cases. The company's operations are based in São Caetano do Sul, Brazil, with a workforce of 51–100 employees.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights2 records

Direct peers

• EMS Pharma: Leading Brazilian pharmaceutical manufacturer specializing in branded generics and prescription products. Comparable to Pharmedic as a Brazilian-headquartered pharma manufacturer serving both specialty/prescription and broader consumer-pharmacy channels.
• Biolab Farmacêutica: Brazilian pharmaceutical company with a specialty branded-generic and prescription portfolio including dermatology and aesthetics products. Comparable to Pharmedic given its Brazilian base, branded-pharma model, and presence in dermatology/aesthetic categories.
• Cristália Produtos Químicos Farmacêuticos: Brazilian pharmaceutical and hospital/specialty manufacturer with a strong presence in rare/specialty medicines and aesthetics (e.g., Dysport, treatments). Comparable to Pharmedic given its Brazilian manufacturing base, orphan/specialty pharma focus, and adjacent aesthetics offering.
• Hypera Pharma: Brazil's largest pharmaceutical company by revenue, operating branded generics, OTC, and consumer health brands. Comparable to Pharmedic as a Brazilian pharma manufacturer with consumer-facing health and personal care products distributed nationally.
• Libbs Farmacêutica: Brazilian pharmaceutical manufacturer with a specialty focus including prescription, oncology, and dermatology categories. Comparable to Pharmedic as a domestically headquartered, specialty-oriented Brazilian pharma producer with dermatology exposure.
• Aché Laboratórios Farmacêuticos: Major Brazilian pharmaceutical company producing branded prescription, OTC, and dermatology products. Comparable to Pharmedic as a Brazilian-based branded pharma manufacturer with dermatology/aesthetics adjacencies and a national commercial footprint.
• Eurofarma Laboratórios: Brazilian diversified pharmaceutical manufacturer headquartered in São Paulo with broad branded generic, specialty, and OTC exposure. Comparable to Pharmedic as a mid-to-large Brazilian pharma producer operating across therapeutic categories, including aesthetics-adjacent and specialty areas.

Broad incumbents

• Galderma: Global dermatology-focused pharmaceutical company with leading franchises in injectable aesthetics (fillers, toxins) and prescription dermatology. Comparable to Pharmedic's aesthetics line as a global incumbent in the same wrinkle-filler category.
• AbbVie (Allergan Aesthetics): Global biopharmaceutical company that owns the leading aesthetics brands (Botox, Juvéderm fillers) through Allergan Aesthetics. Comparable as a broad incumbent in the same injectable aesthetics/wrinkle-filler category that Pharmedic serves.

Regional players

• Genomma Lab Internacional: Mexico-headquartered pharmaceutical and personal care company with broad Latin American distribution across OTC, skincare, and aesthetics-adjacent brands. Comparable to Pharmedic as a Latin American pharma/personal-care operator targeting similar consumer and pharmacy channels.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/pharmedicbr
• Facebookfacebook.com/pharmedicph
• LinkedInlinkedin.com/company/pharmedic-pharmaceuticals

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmedic Pharmaceuticals